Skip to search formSkip to main contentSkip to account menu

GM 611

Known as: GM-611, GM611 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mitemcinal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Stimulatory action of mitemcinal (GM‐611), an acid‐resistant non‐peptide motilin receptor agonist, on colonic motor activity and defecation: spontaneous and mitemcinal‐induced giant migrating…
Abstract  The aim of this study was to characterize giant migrating contractions (GMCs) during spontaneous defecation in dogs and… 
2008
2008
Characterization of Multinuclear Hepatocytes Induced in Rats by Mitemcinal (GM-611), an Erythromycin Derivative
Mitemcinal is an erythromycin derivative with motilin agonistic action, developed as a gastrointestinal motor-activating agent… 
2008
2008
Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
2007
2007
Effects of Motilin and Mitemcinal (GM-611) on Gastrointestinal Contractile Activity in Rhesus Monkeys In Vivo and In Vitro
Neither the presence of motilin receptors nor their action has been investigated in monkeys. The object of this study was to… 
2007
2007
Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin.
Mitemcinal (GM-611) is a novel erythromycin-derived prokinetic agent that acts as an agonist at the motilin receptor… 
2006
2006
The GERD market
Gastroesophageal reflux disease (GERD) occurs when stomach contents flow into the esophagus. GERD sufferers often complain of a… 
2006
2006
Desensitizing potency of the motilide mitemcinal (GM-611) in CHO-cells expressing the motilin receptor (MTLR)
Review
2001
Review
2001
GM-611 (Chugai Pharmaceutical).
GM-611 is an erythromycin derivative that acts as an agonist at the motilin receptor. It is being developed by Chugai as a… 
2000
2000
Neural and muscular receptors for motilin in the rabbit colon
1995
1995
A novel and selective motilin receptor antagonist, GM-109, inhibits contractile response to GM-611, an acid-stable erythromycin a derivative, in the rabbit small intestine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)